Geode Capital Management
MNPR icon

Geode Capital Management’s Monopar Therapeutics MNPR Stock Holding History

Geode Capital Management’s Portfolio MNPR Stock Details MNPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.48M Buy
99,918
+911
+0.9% +$55K ﹤0.01% 2692
2025
Q4 		$6.47M Buy
99,007
+14,046
+17% +$1.15M ﹤0.01% 2630
2025
Q3 		$6.94M Sell
84,961
-11,958
-12% -$535K ﹤0.01% 2618
2025
Q2 		$3.47M Buy
96,919
+48,379
+100% +$1.76M ﹤0.01% 2914
2025
Q1 		$1.77M Buy
48,540
+9,944
+26% +$358K ﹤0.01% 3086
2024
Q4 		$849K Buy
38,596
+24,530
+174% +$412K ﹤0.01% 3426
2024
Q3 		$94.8K Buy
14,066
+2,059
+17% +$6.89K ﹤0.01% 4118
2024
Q2 		$44.9K Buy
12,007
+3,767
+46% +$13.3K ﹤0.01% 4303
2024
Q1 		$28.1K Hold
8,240
– – ﹤0.01% 4430
2023
Q4 		$14K Hold
8,240
– – ﹤0.01% 4561
2023
Q3 		$23.5K Sell
8,240
-138
-2% -$482 ﹤0.01% 4589
2023
Q2 		$35.8K Hold
8,378
– – ﹤0.01% 4575
2023
Q1 		$59.5K Hold
8,378
– – ﹤0.01% 4477
2022
Q4 		$99K Buy
8,378
+544
+7% +$6.64K ﹤0.01% 4407
2022
Q3 		$59K Hold
7,834
– – ﹤0.01% 4730
2022
Q2 		$85K Hold
7,834
– – ﹤0.01% 4645
2022
Q1 		$100K Hold
7,834
– – ﹤0.01% 4662
2021
Q4 		$126K Hold
7,834
– – ﹤0.01% 4650
2021
Q3 		$189K Buy
7,834
+2,082
+36% +$53.9K ﹤0.01% 4475
2021
Q2 		$169K Buy
5,752
+473
+9% +$13.5K ﹤0.01% 4399
2021
Q1 		$163K Buy
+5,279
New +$193K ﹤0.01% 4176

Other funds holding MNPR

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management's MNPR Position: Q1 2026 in Review

Geode Capital Management increased its Monopar Therapeutics (MNPR) stake by 0.92% in Q1 2026, buying an estimated $55K and bringing the position to 99,918 shares worth $5.48M. The position accounts for ﹤0.01% of the portfolio, ranked #2692.

Geode Capital Management first reported a position in MNPR in Q1 2021 and has held it in 21 quarters since. The position peaked at $6.94M in Q3 2025. 82 funds tracked by Wall St. Rank hold MNPR as of Q1 2026.

  • Geode Capital Management held 99,918 shares of Monopar Therapeutics worth $5.48M as of Q1 2026.
  • Geode Capital Management bought 911 Monopar Therapeutics shares in Q1 2026, an estimated $55K.
  • Monopar Therapeutics made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #2692 holding.
  • Geode Capital Management first reported a position in Monopar Therapeutics in Q1 2021 and has held it in 21 quarters since.
  • Geode Capital Management's Monopar Therapeutics position peaked at $6.94M in Q3 2025.
  • 82 funds tracked by Wall St. Rank held Monopar Therapeutics as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.